Epidemiology of invasive cutaneous melanoma
Open accessThe DOI matches its Crossref record; 53 of the 55 references it cites were found in a registry or an index.
Abstract
Data are presented on the current incidence of melanoma with recent and predicted future trends illustrating a likely continuing increase in incidence. Risk factors for developing melanoma are discussed, including current known melanoma susceptibility genes. Phenotypic markers of high-risk subjects include high counts of benign melanocytic naevi. Other risk factors considered include exposure to natural and artificial ultraviolet radiation, the effect of female sex hormones, socioeconomic status, occupation, exposure to pesticides and ingestion of therapeutic drugs including immunosuppressives and non-steroidal anti-inflammatory drugs. Aids to earlier diagnosis are considered, including public education, screening and use of equipment such as the dermatoscope. Finally, the current pattern of survival and mortality is described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Diagnostic accuracy of dermoscopy
Kittler, H., Pehamberger, H., Wolff, K., & Binder, M. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00679-4 · Cited by 1,349 · cited 1×
“Available data indicate that training in dermatoscope use improves both sensitivity and specificity of clinical diagnosis by non-expert clinicians, but without training, preoperative diagnostic accuracy is reduced [49, 50].”
BackgroundKarim-Kos, H. E., de Vries, E., Soerjomataram, I., Lemmens, V., Siesling, S., & Coebergh, J. W. W. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.12.015 · Cited by 754 · cited 1×
“and Estonia, and also eastern European countries such as Belarus and Serbia (Table 1), although recent data show a rise in incidence in many east European countries [2].”
BackgroundThe International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer (2007) · International Journal of Cancer · doi:10.1002/ijc.22453 · Cited by 561
Lindelöf, B., Sigurgeirsson, B., Gäbel, H., & Stern, R. S. (2000) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2000.03703.x · Cited by 559 · cited 1×
“Studies from Sweden and the Netherlands show no increase in melanoma incidence over that expected in these countries [37, 38], while studies from the USA and UK show a significantly increased risk, 3.”
BackgroundMelanocytic Nevi, Solar Keratoses, and Divergent Pathways to Cutaneous Melanoma
Whiteman, D. C., Watt, P., Purdie, D. M., Hughes, M. C., Hayward, N. K., & Green, A. C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.11.806 · Cited by 449
ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma
Gudbjartsson, D. F., Sulem, P., Stacey, S. N., Goldstein, A. M., Rafnar, T., Sigurgeirsson, B., Benediktsdottir, K. R., Thorisdottir, K., Ragnarsson, R., Sveinsdottir, S. G., et al. (2008) · Nature Genetics · doi:10.1038/ng.161 · Cited by 354 · cited 1×
“The second study examined DNA samples from 2121 European melanoma patients and 40 000 controls and reported pigmentation gene variants ASIP and TYR associated with melanoma [18].”
BackgroundMC1R variants, melanoma and red hair color phenotype: A meta‐analysis
Raimondi, S., Sera, F., Gandini, S., Iodice, S., Caini, S., Maisonneuve, P., & Fargnoli, M. C. (2008) · International Journal of Cancer · doi:10.1002/ijc.23396 · Cited by 349 · cited 1×
“Subjects with red hair have a higher proportion of three MC1R variants, currently known as red-hair variants, and it has been a matter of discussion whether these variants are also more common in non-red-haired patients with sporadic melanoma [15].”
BackgroundBenign melanocytic naevi as a risk factor for malignant melanoma.
Swerdlow, A. J., English, J., MacKie, R. M., O'Doherty, C. J., Hunter, J. A., Clark, J., & Hole, D. J. (1986) · BMJ · doi:10.1136/bmj.292.6535.1555 · Cited by 344 · cited 1×
“Studies from Australasia [19], North America [20] and Europe [21] have all shown that a high count of banal melanocytic naevi is a major risk factor for sporadic melanoma.”
BackgroundSelf-citation
Research works printed but not linked: 1
- Curiel C Gomex ML Atkins T Association between use of non steroidal anti-inflammatories and of melanoma: a case control study. J Clin Oncol 2007 25 (Supp): abstract 8500
Cited by
Human skin pigmentation as an adaptation to UV radiation
Jablonski, N. G., & Chaplin, G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914628107 · Cited by 728
Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification.
Rastrelli, M., Tropea, S., Rossi, C. R., & Alaibac, M. (2014) · PubMed · Cited by 966
Schadendorf, D., Fisher, D. E., Garbe, C., Gershenwald, J. E., Grob, J.-J., Halpern, A., Herlyn, M., Marchetti, M. A., McArthur, G., Ribas, A., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.3 · Cited by 613
Self-citationRecent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006
Jemal, A., Saraiya, M., Patel, P., Cherala, S. S., Barnholtz-Sloan, J., Kim, J., Wiggins, C. L., & Wingo, P. A. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.04.032 · Cited by 385
Occupational Pesticide Exposures and Cancer Risk: A Review
Alavanja, M. C. R., & Bonner, M. R. (2012) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2012.632358 · Cited by 371
“Melanoma The incidence of cutaneous melanoma has steadily increased over recent decades and there is striking risk variation by geographic location (Mackie et al. 2009).”
Martinet, L., Le Guellec, S., Filleron, T., Lamant, L., Meyer, N., Rochaix, P., Garrido, I., & Girard, J.-P. (2012) · OncoImmunology · doi:10.4161/onci.20492 · Cited by 193
“Although primary cutaneous melanoma is curable in its early stages with surgical resection, patients with metastatic melanoma have a median survival of less than 1 y.(1) Immunological factors have been shown to constitute a major predictor of good clinical outcome in solid cancers, including breast, colorectal and ova…”
Oncolytic virus therapy in cancer: A current review
Santos Apolonio, J., Lima de Souza Gonçalves, V., Cordeiro Santos, M. L., Silva Luz, M., Silva Souza, J. V., Rocha Pinheiro, S. L., de Souza, W. R., Sande Loureiro, M., & de Melo, F. F. (2021) · World Journal of Virology · doi:10.5501/wjv.v10.i5.229 · Cited by 162
Li, R., Zhang, L., Jia, L., Duan, Y., Li, Y., Bao, L., & Sha, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100893 · Cited by 159
“Melanoma is the most aggressive type of skin cancer, characterized by a rapid progression, metastasis to regional lymph nodes and distant organs as well as a limited efficiency of therapeutics [1].”
BackgroundRoles of UVA radiation and DNA damage responses in melanoma pathogenesis
Khan, A. Q., Travers, J. B., & Kemp, M. G. (2018) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22176 · Cited by 152
“Mela- noma is a major public health concern because of its rapidly growing incidence (at a rate of 3–7% per year for fair-skinned individuals), which is projected to double every 10–20 years [Lens and Dawes, 2004; Leiter and Garbe, 2008; MacKie et al., 2009].”
BackgroundThymoquinone suppresses metastasis of melanoma cells by inhibition of NLRP3 inflammasome
Ahmad, I., Muneer, K. M., Tamimi, I. A., Chang, M. E., Ata, M. O., & Yusuf, N. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.03.027 · Cited by 153
Melanoma-induced immunosuppression and its neutralization
Umansky, V., & Sevko, A. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.003 · Cited by 146
“USA and Europe faster than any those of other cancers [1,2].”
BackgroundVizoso, M., Ferreira, H. J., López-Serra, P., Carmona, F. J., Martínez‐Cardús, A., Girotti, M. R., Villanueva, A., Guil, S., Moutinho, C., Liz, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3863 · Cited by 132
Use of acetochlor and cancer incidence in the A gricultural H ealth S tudy
Lerro, C. C., Koutros, S., Andreotti, G., Hines, C. J., Blair, A. E., Lubin, J. H., Ma, X., Zhang, Y., & Freeman, L. E. B. (2015) · International Journal of Cancer · doi:10.1002/ijc.29416 · Cited by 136
Moretti, S., Massi, D., Farini, V., Baroni, G., Parri, M., Innocenti, S., Cecchi, R., & Chiarugi, P. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2012.175 · Cited by 133
Papaspyridonos, M., Matei, I., Huang, Y., do Rosario Andre, M., Brazier-Mitouart, H., Waite, J. C., Chan, A. S., Kalter, J., Ramos, I., Wu, Q., et al. (2015) · Nature Communications · doi:10.1038/ncomms7840 · Cited by 116
Functional and Clinical Relevance of Chondroitin Sulfate Proteoglycan 4
Campoli, M. R., Ferrone, S., & Wang, X. (2010) · Advances in cancer research · doi:10.1016/b978-0-12-380890-5.00003-x · Cited by 129
Melanoma Chemotherapy Leads to the Selection of ABCB5-Expressing Cells
Chartrain, M., Riond, J., Stennevin, A., Vandenberghe, I., Gomes, B., Lamant, L., Meyer, N., Gairin, J. E., Guilbaud, N., & Annereau, J. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036762 · Cited by 118
“Melanoma is one of the most aggressive form of skin cancer and its incidence is increasing worldwide, especially where fair-skinned people receive excessive sun exposure [1–3].”
Sevko, A., Sade-Feldman, M., Kanterman, J., Michels, T., Falk, C. S., Umansky, L., Ramacher, M., Kato, M., Schadendorf, D., Baniyash, M., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.444 · Cited by 111
“Human malignant melanoma, known for its poor response to therapeutics, is one of the fastest growing cancers (MacKie et al., 2009).”
BackgroundSun, Y., Shen, Y., Liu, Q., Zhang, H., Jia, L., Chai, Y., Jiang, H., Wu, M., & Li, Y. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2024.09.035 · Cited by 111
Chatzinasiou, F., Lill, C. M., Kypreou, K., Stefanaki, I., Nicolaou, V., Spyrou, G., Evangelou, E., Roehr, J. T., Kodela, E., Katsambas, A., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr219 · Cited by 110
“Metastatic melanoma is the leading cause of skin cancer– related mortality and is characterized by a poor prognosis and limited treatment options (1,2).”
BackgroundAcquaviva, J., Smith, D. L., Jimenez, J.-P., Zhang, C., Sequeira, M., He, S., Sang, J., Bates, R. C., & Proia, D. A. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0481 · Cited by 101
“rates for many cancer types are showing encouraging declines (2), the worldwide incidence of melanoma continues to increase (3).”
BackgroundTime Course and Pattern of Metastasis of Cutaneous Melanoma Differ between Men and Women
Mervic, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032955 · Cited by 102
“Mortality figures over the past decades show trends that differ from those for incidence, with a much lower rate of mortality increase than that recorded for incidence [1].”
BackgroundCheng, P. F., Shakhova, O., Widmer, D. S., Eichhoff, O. M., Zingg, D., Frommel, S. C., Belloni, B., Raaijmakers, M. I., Goldinger, S. M., Santoro, R., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0594-4 · Cited by 100
“It is the most life-threatening neoplasm of the skin and is considered a major health problem due to rising incidence and mortality rates [2,3].”
BackgroundA Deep Learning Based Framework for Diagnosing Multiple Skin Diseases in a Clinical Environment
Zhu, C.-Y., Wang, Y.-K., Chen, H.-P., Gao, K.-L., Shu, C., Wang, J.-C., Yan, L.-F., Yang, Y.-G., Xie, F.-Y., & Liu, J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.626369 · Cited by 100
“But in Asia, the prevalence of cutaneous diseases is very distinct from that of Western countries, for example, the average annual age-adjusted incidence rate of melanoma in Asian population was reported as 1/100,000 (25, 26).”
BackgroundPooled cohort study on height and risk of cancer and cancer death
Wirén, S., Häggström, C., Ulmer, H., Manjer, J., Bjørge, T., Nagel, G., Johansen, D., Hallmans, G., Engeland, A., Concin, H., et al. (2014) · Cancer Causes & Control · doi:10.1007/s10552-013-0317-7 · Cited by 95
“Possible explanations for this association are increased skin surface or higher naevi count in taller individuals, or differences in distribution of other risk factors such as sun exposure [30].”
BackgroundBurden of melanoma in China, 1990–2017: Findings from the 2017 global burden of disease study
Wu, Y., Wang, Y., Wang, L., Yin, P., Lin, Y., & Zhou, M. (2019) · International Journal of Cancer · doi:10.1002/ijc.32764 · Cited by 103
“Most data from different countries showed higher melanoma mortality in males, while an European study reported a higher incidence in females from 1998 to 2002.(4) Very few large-scale studies were carried out in Asia, especially in China.”
ResultTromme, I., Sacré, L., Hammouch, F., Legrand, C., Marot, L., Vereecken, P. M., Théate, I., van Eeckhout, P., Richez, P., Baurain, J. F., et al. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11042.x · Cited by 103
A Melanoma Molecular Disease Model
Vidwans, S. J., Flaherty, K. T., Fisher, D. E., Tenenbaum, J. M., Travers, M., & Shrager, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018257 · Cited by 106
“Melanoma is the most aggressive form of skin cancer and its incidence is on the rise worldwide [1].”
BackgroundLong non‐coding RNAs in melanoma
Yu, X., Zheng, H., Tse, G., Chan, M. T. V., & Wu, W. K. K. (2018) · Cell Proliferation · doi:10.1111/cpr.12457 · Cited by 93
ERK and PDE4 cooperate to induce RAF isoform switching in melanoma
Marquette, A., André, J., Bagot, M., Bensussan, A., & Dumaz, N. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2022 · Cited by 89
“2022" language="eng" relation="no"> Cutaneous melanoma is the deadliest form of skin cancer, and its incidence is increasing at a rate of 2–5% per yea”
BackgroundJia, D., Jiang, H., Zhang, Y., Zhang, Y., Qian, L.-L., & Zhang, Y. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.68221 · Cited by 95
Brożyna, A. A., Jóźwicki, W., & Slominski, A. T. (2014) · PubMed · Cited by 91
Guo, W., Zhu, L., Zhu, R., Chen, Q., Wang, Q., & Chen, J. (2019) · eLife · doi:10.7554/elife.44310 · Cited by 87
“Introduction Cutaneous melanoma (CM) is a malignant neoplasia characterized by rapid progression, metastasis to regional lymph nodes as well as distant organs, and limited responsiveness to therapeutics (MacKie et al., 2009).”
BackgroundJúnior, R. G. D. O., Bonnet, A., Braconnier, E., Groult, H., Prunier, G., Beaugeard, L., Grougnet, R., Almeida, J. R. G. D. S., Ferraz, C. A. A., & Picot, L. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.02.013 · Cited by 90
Melanoma: Epidemiology, Diagnosis, Treatment, and Outcomes
Tuong, W., Cheng, L. S., & Armstrong, A. W. (2011) · Dermatologic Clinics · doi:10.1016/j.det.2011.08.006 · Cited by 92
“Nevi The number of nevi is positively correlated with UV exposure and is used as a surrogate measurement of UV-induced cutaneous damage.(49) Studies have shown that approximately 25% of melanoma cases are attributable to the presence of 1 or more atypical nevi (also known as a dysplastic nevi), whereas 27% of melanoma…”
BackgroundCiocan, D. M., Barbe, C., Aubin, F., Granel‐Brocard, F., Lipsker, D. M., Velten, M., Dalac, S., Truchetet, F., Michel, C., Mitschler, A., et al. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.706 · Cited by 78
Genetics and epigenetics of cutaneous malignant melanoma: A concert out of tune
van den Hurk, K., Niessen, H. E. C., Veeck, J., van den Oord, J. J., Steensel, M. A. M. V., Hausen, A. Z., van Engeland, M., & Winnepenninckx, V. J. L. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.03.011 · Cited by 79
Cutaneous Melanoma In Situ: Translational Evidence from a Large Population-Based Study
D, S. M. M., & Nitti, D. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0340 · Cited by 69
Extracellular adenosine metabolism in immune cells in melanoma
Umansky, V., Shevchenko, I., Bazhin, A. V., & Utikal, J. S. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1553-8 · Cited by 73
“Its incidence and death rates have been increasing in different countries faster than those of other cancers [1, 2].”
BackgroundOvercoming immunosuppression in the melanoma microenvironment induced by chronic inflammation
Umansky, V., & Sevko, A. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1164-6 · Cited by 69
“Malignant skin melanoma, notorious for its aggressive clinical behavior, proclivity for distant metastasis and poor response to currently applied therapeutics such as chemoand radio-therapy, is one of the fastest increasing cancers worldwide [1, 2].”
Sex disparities in melanoma outcomes: The role of biology
Nosrati, A., & Wei, M. L. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.06.018 · Cited by 66
Micro RNA ‐206 induces G 1 arrest in melanoma by inhibition of CDK 4 and C yclin D
Georgantas, R. W., Streicher, K. L., Luo, X., Greenlees, L. M., Zhu, W., Liu, Z., Brohawn, P. Z., Morehouse, C. A., Higgs, B. W., Richman, L. K., et al. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12200 · Cited by 71
“Premalignant and early malignant melanomas are generally easily treated by resection, but metastatic melanoma is largely untreatable, with a 5-yr survival rate of less than 5% and a median survival of only 6–12 months post-diagnosis (MacKie et al., 2009).”
BackgroundInfluentialLelliott, E. J., McArthur, G. A., Oliaro, J., & Sheppard, K. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661737 · Cited by 65
“Melanoma predominately arises through the accumulation of genetic mutations in a type of pigment-producing skin cell, called a melanocyte, induced by repeated exposure to UV radiation or other environmental factors (2, 3, 19).”
BackgroundEpidemiology of Lentigo Maligna and Lentigo Maligna Melanoma in the Netherlands, 1989–2013
Greveling, K., Wakkee, M., Nijsten, T. E. C., van den Bos, R. R., & Hollestein, L. M. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.06.014 · Cited by 64
“This is different compared with cutaneous melanoma, in which there is a predominance found in women in European countries, and the opposite is found in Australia and North America (Arnold et al., 2014; Coory et al., 2006; Garbe and Leiter, 2009; MacKie et al., 2009).”
Reactive oxygen species and melanoma: an explanation for gender differences in survival?
Joosse, A., de Vries, E., van Eijck, C. H. J., Eggermont, A. M. M., Nijsten, T. E. C., & Coebergh, J. W. W. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00694.x · Cited by 64
“However, neither preg- nancy, nor oral contraceptives and hormone replace- ment seem to influence melanoma survival (Mackie et al., 2009).”
BackgroundSelf-citationHausauer, A. K., Swetter, S. M., Cockburn, M., & Clarke, C. A. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2011.44 · Cited by 68
“Socioeconomic differentials in melanoma have previously been suggested to relate to differences in sun-exposure behaviors.(8,12) Affluent women have been reported to have more leisure time, during which they may pursue outdoor activities such as gardening, playing sports, or walking(22); they may travel more frequentl…”
BackgroundThe forthcoming inexorable decline of cutaneous melanoma mortality in light-skinned populations
Autier, P., Koechlin, A., & Boniol, M. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.01.056 · Cited by 63
“Starting in Oceania in the 1970-80s, sun protection of children has become increasingly common with the recognition that sun exposure and sunburn experience during childhood causes irreversible damages to the skin and are strong risk factors for skin cancer in adult life (MacKie et al., 2009; Marks, 1990).”
BackgroundRivera, A., Nan, H., Li, T., Qureshi, A. A., & Cho, E. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0303 · Cited by 58
Sigalotti, L., Fratta, E., Bidoli, E., Covre, A., Parisi, G., Colizzi, F., Coral, S., Massarut, S., Kirkwood, J. M., & Maio, M. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-78 · Cited by 63
“Cutaneous melanoma (CM) is a very aggressive neoplasm of growing incidence and mortality in industrialized countries, and the leading cause of skin cancerrelated deaths worldwide [ 1 ].”
BackgroundYuan, H., Liu, H., Liu, Z., Zhu, D. K., Amos, C. I., Fang, S., Lee, J. E., & Wei, Q. (2015) · International Journal of Cancer · doi:10.1002/ijc.29429 · Cited by 57
“Much of this increase has been seen in relatively young adults, and, consequently, the number of life-years lost per CM death is higher than that of most other solid tumors.(2) Though recent advances in therapies for metastatic CM have shown some progress,(3,4) CM with distant metastasis still has a grim prognosis wit…”
CtBP1 Is Expressed in Melanoma and Represses the Transcription of p16INK4a and Brca1
Deng, H., Liu, J., Deng, Y., Han, G., Shellman, Y. G., Robinson, S. E., Tentler, J. J., Robinson, W. A., Norris, D. A., Wang, X., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.487 · Cited by 56
“Multiple genetic events have been related to the pathogenesis of melanoma (MacKie et al., 2009; Pho et al., 2006).”
BackgroundMangana, J., Levesque, M. P., Karpova, M. B., & Dummer, R. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.665872 · Cited by 56
“The incidence of melanoma is increasing worldwide with rates as high as 3 -- 5% per year in high-risk populations [1,2].”
BackgroundFlaherty, L. E., Hamid, O., Linette, G. P., Schuchter, L. M., Hallmeyer, S., Gonzalez, R. C., Cowey, C. L., Pavlick, A. C., Kudrik, F. J., Curti, B. D., et al. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000024 · Cited by 55
“Unable to evaluate 10 (4) 2 (3) 7 (3) 3 (10) 1 (2) 9 (5)”
BackgroundInfluentialWhole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients
Sigalotti, L., Covre, A., Fratta, E., Parisi, G., Sonego, P., Colizzi, F., Coral, S., Massarut, S., Kirkwood, J. M., & Maio, M. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-185 · Cited by 55
“Background Cutaneous melanoma (CM) is an aggressive neoplasm with growing incidence and mortality rates in industrialized countries, and the leading cause of skin cancerrelated deaths worldwide [1].”
BackgroundGeller, A. C., Greinert, R., Sinclair, C., Weinstock, M. A., Aitken, J. F., Boniol, M., Capellaro, M., Doré, J., Elwood, M., Fletcher, S. W., et al. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.03.006 · Cited by 55
“Skin cancer incidence is increasing worldwide in white populations [1], and mortality from skin cancer, which is primarily due to”
BackgroundA six-long non-coding RNA signature predicts prognosis in melanoma patients
Yang, S., Xu, J., & Zeng, X. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4268 · Cited by 55
“It is the most aggressive type of skin cancer and caused 59,800 deaths globally in 2015 (1,2).”
The epidemiology, prevention, and detection of melanoma.
(2010) · PubMed Central · Cited by 54
Accuracy of Diagnostic Biopsy for Cutaneous Melanoma: Implications for Surgical Oncologists
Hieken, T. J., Hernández-Irizarry, R., Boll, J. M., & Coleman, J. E. J. (2013) · International Journal of Surgical Oncology · doi:10.1155/2013/196493 · Cited by 54
“The thickness of the primary melanoma, as measured histopathologically, guides treatment and provides important prognostic and staging information; a proper dermatopathologist-reviewed diagnostic biopsy is essential for appropriate management of the newly diagnosed melanoma patient.”
BackgroundNodin, B., Fridberg, M., Jonsson, L., Bergman, J., Uhlén, M., & Jirström, K. (2012) · Diagnostic Pathology · doi:10.1186/1746-1596-7-82 · Cited by 55
“Introduction Malignant melanoma is an aggressive form of cancer with an increasing incidence and mortality worldwide [1].”
New developments in sentinel node staging in melanoma: controversies and alternatives
van Akkooi, A. C. J., Voit, C. A., Verhoef, C. K., & Eggermont, A. M. M. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328337aa78 · Cited by 53
Self-citationMulder, E. E. A. P., de Joode, K., Litière, S., ten Tije, A. J., Suijkerbuijk, K. P. M., Boers‐Sonderen, M. J., Hospers, G. A. P., de Groot, J. W. B., van den Eertwegh, A. J. M., Aarts, M. J. B., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08018-w · Cited by 57
“Although melanoma has a lower incidence than other types of skin cancer, melanoma is responsible for the majority of skin cancer-related deaths worldwide, and its incidence is increasing [2, 3].”
BackgroundCachin, F., Miot-Noirault, E., Gillet, B., Isnardi, V., Labeille, B., Payoux, P., Meyer, N., Cammilleri, S., Gaudy‐Marqueste, C., Razzouk‐Cadet, M., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.123554 · Cited by 58
“It is the second most common cancer among patients in their second decade (2).”
BackgroundKvaskoff, M., Whiteman, D. C., Zhao, Z., Montgomery, G. W., Martin, N. G., Hayward, N. K., & Duffy, D. L. (2011) · Twin Research and Human Genetics · doi:10.1375/twin.14.5.422 · Cited by 57
“Its main risk factors include ultraviolet radiation (UVR), pigmentation, and nevus count (MacKie et al., 2009).”
Ebner, S., Lang, R., Mueller, E. E., Eder, W., Oeller, M., Moser, A., Koller, J., Paulweber, B., Mayr, J. A., Sperl, W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027192 · Cited by 53
“Due to the fact that its worldwide incidence in Caucasian populations has been rising steadily for several decades [1], malignant melanoma has become an important public health issue and its early detection remains vital to lowering mortality [2].”
BackgroundAvram, G., Sánchez‐Sendra, B., Martín, J. M., Terrádez, L., Ramos, D., & Monteagudo, C. (2013) · Histopathology · doi:10.1111/his.12235 · Cited by 49
“Although, in the early stages, it is usually curable by surgical resection, the rates of mortality in metastatic melanoma are still high, because of an almost complete absence of a truly effective treatment for this malignancy.(1,2) A series of complex interactions and signalling pathways between tumour cells and the…”
BackgroundSTAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma
Momtaz, S., Niaz, K., Maqbool, F., Abdollahi, M. R., Rastrelli, L., & Nabavi, S. M. (2016) · BioFactors · doi:10.1002/biof.1345 · Cited by 53
“Genistein and resveratrol have been used in clinical studies due to their high efficacy against skin melanoma [19].”
BackgroundUlrich, J., van Akkooi, A. C. J., Eggermont, A. M. M., & Voit, C. A. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.11.115 · Cited by 47
Self-citationGrant, W. B. (2009) · Dermato-Endocrinology · doi:10.4161/derm.1.4.9841 · Cited by 47
Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can)
Nagel, G., Bjørge, T., Stocks, T., Manjer, J., Hallmans, G., Edlinger, M., Häggström, C., Engeland, A., Johansen, D., Kleiner, A., et al. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10974.x · Cited by 48
Jin, J.-L., Gong, J., Yin, T., Lu, Y., Xia, J.-J., Xie, Y., Di, Y., He, L., Guo, J., Sun, J., et al. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.12.004 · Cited by 47
“Worldwide, the incidence and mortality of cutaneous malignant melanoma are continuously increasing (Garbe and Leiter, 2009; MacKie et al., 2009).”
BackgroundEisen, T. G., Marais, R., Affolter, A., Lorigan, P. C., Robert, C., Corrie, P. G., Ottensmeier, C. H. H., Chevreau, C., Chao, D., Nathan, P., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.257 · Cited by 46
“…UK Keywords: melanoma; sorafenib; dacarbazine; combination therapy; biomarker The incidence of melanoma worldwide has been on the rise for at least 30 years, with rates as high as 3–5% per year in high-risk populations (Danson and Lorigan, 2005; MacKie et al, 2009; American Cancer Society, 2010).”
BackgroundIdentification of a melanoma susceptibility locus and somatic mutation inTET2
Song, F., Amos, C. I., Lee, J. E., Lian, C. G., Fang, S., Liu, H., MacGregor, S., Iles, M. M., Law, M. H., Lindeman, N. I., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu140 · Cited by 48
“Much of this increase has been seen in relatively young adults, and consequently, the number of life years lost per melanoma death is higher than that of most other solid tumors (3).”
BackgroundMooney, Á., Corry, A. J., Ruairc, C. N., Mahgoub, T., O'Sullivan, D., O’Donovan, N., Crown, J. P., Varughese, S., Draper, S. M., Rai, D. K., et al. (2010) · Dalton Transactions · doi:10.1039/c0dt00377h · Cited by 45
Towards new therapeutic approaches for malignant melanoma
Pacheco, I., Buzea, C., & Tron, V. A. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239941100202x · Cited by 54
Importance of tumor load in the sentinel node in melanoma: clinical dilemmas
van Akkooi, A. C. J., Verhoef, C. K., & Eggermont, A. M. M. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.100 · Cited by 45
“00 mm Breslow thickness) melanomas with an excellent prognosis”
BackgroundSelf-citationGonçalves, F. D. T., Francisco, G., de Souza, S. P., Luiz, O. D. C., Neto, C. F., Sanches, J. A., Chammas, R. J., Gattás, G. J. F., & Eluf‐Neto, J. (2011) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2011.06.003 · Cited by 45
“Cutaneous melanoma shows high rates of mortality and its incidence has increased worldwide over the last century [1].”
BackgroundJuin, C., Júnior, R. G. D. O., Fleury, A., Oudinet, C., Pytowski, L., Bérard, J., Nicolau, É., Thiéry, V., Lanneluc, I., Beaugeard, L., et al. (2018) · Revista Brasileira de Farmacognosia · doi:10.1016/j.bjp.2018.05.009 · Cited by 49
Birch‐Johansen, F., Jensen, A., Olesen, A. B., Christensen, J., Tjønneland, A. M., & Kjær, S. K. (2012) · Cancer Causes & Control · doi:10.1007/s10552-011-9887-4 · Cited by 42
Ezzedine, K., Latreille, J., Kesse‐Guyot, E., Galan, P., Herçberg, S., Guinot, C., & Malvy, D. J.-M. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.06.008 · Cited by 45
de Assis, L. V. M., Moraes, M. N., Magalhães-Marques, K. K., Kinker, G. S., Cruz‐Machado, S. D. S., & Castrucci, A. M. D. L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041065 · Cited by 42
“Etiologically, melanoma is a multifactorial disease and is associated with chronic environmental and artificial UV exposure, sunburn history in early childhood, reduced skin pigmentation, melanocytic nevi, family history, and genetic susceptibility [23,24].”
BackgroundVariants at the 9p21 locus and melanoma risk
Maccioni, L., Rachakonda, P. S., Bermejo, J. L., Planelles, D., Requena, C., Hemminki, K., Nagore, E., & Kumar, R. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-325 · Cited by 43
“The risk factors associated with melanoma include environmental sun exposure and genetically determined host factors as skin color, eye color, hair color, freckling and the presence and number of nevi [2-6].”
BackgroundMrazek, A. A., & Chao, C. (2014) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.07.003 · Cited by 39
“6% each year, while the death rates have remained stable over time (1); furthermore, a similar trend has been observed on a global scale within the last two decades, with the highest incidences of melanoma in Australia and New Zealand (2,3).”
BackgroundInfluentialVaid, M., Singh, T., Prasad, R., & Katiyar, S. K. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22208 · Cited by 42
Lyth, J., Eriksson, H., Hansson, J., Ingvar, C., Jansson, M., Lapins, J., Månsson‐Brahme, E., Naredi, P. L. J., Stierner, U. K., Ullenhag, G. J., et al. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13483 · Cited by 39
Saha, B., Bellare, G. P., Subramanian, M., Gupta, P., Tyagi, M., Patro, B. S., & Chattopadhyay, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.085 · Cited by 38
Lai, M., Rocca, V. L., Amato, R., Freer, G., & Pistello, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143436 · Cited by 42
“The incidence of melanoma has increased dramatically over the last 50 years [3].”
BackgroundThe Role of cGAS-STING in Age-Related Diseases from Mechanisms to Therapies
Zheng, W., Feng, D., Xiong, X., Liao, X., Wang, S., Xu, H., Le, W., Wei, Q., & Yang, L. (2023) · Aging and Disease · doi:10.14336/ad.2023.0117 · Cited by 50
Chemovirotherapy of Malignant Melanoma with a Targeted and Armed Oncolytic Measles Virus
Kaufmann, J. K., Bossow, S., Grossardt, C., Sawall, S., Kupsch, J., Erbs, P., Hassel, J. C., Kalle, C. V., Enk, A., Nettelbeck, D. M., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.459 · Cited by 43
“Malignant melanoma is the most common form of fatal skin cancer (Siegel et al., 2012) and incidences continue to rise (MacKie et al., 2009).”
Prognostic factors in patients with localized primary cutaneous melanoma.
Mervic, L. (2012) · PubMed · Cited by 37
The burden of malignant melanoma – Lessons to be learned from Austria
Itzinger-Monshi, B., Vujic, M., Kivaranovic, D., Sesti, A., Oberaigner, W., Vujic, I., Ortiz‐Urda, S., Posch, C., Feichtinger, H. G., Hackl, M., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.11.026 · Cited by 37
“5 fold increase since 1983 similar to increments seen in many Western countries [4,6,15,20,21].”
MethodResultKong, Q., Lv, J., Yan, S., Chang, K., & Wang, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102975 · Cited by 42
“During the last three decades, morbidity of melanoma has increased [2], and the death rate continues to increase faster than the rate of many cancers [3], whereas that for many other types of tumors have decreased [4].”
BackgroundThe Effectiveness of a Population-Based Skin Cancer Screening Program: Evidence from Germany
Kaiser, M., Schiller, J., & Schreckenberger, C. (2016) · The European Journal of Health Economics · doi:10.1007/s10198-017-0888-4 · Cited by 36
Yu, L., Favoino, E., Wang, Y., Ma, Y., Deng, X., & Wang, X. (2011) · Immunologic Research · doi:10.1007/s12026-011-8232-z · Cited by 39
“It is estimated that the incidence of malignant melanoma increases at a rate of 5% per year [ 1 ].”
BackgroundZiefle, S., Egberts, F., Heinze, S., Volkenandt, M., Schmid-Wendtner, M.-H., Tilgen, W., Linse, R., Boettjer, J., VOGT, T. M., Spieth, K., et al. (2011) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31821b7a4b · Cited by 37
“Over the last decade, the incidence and mortality of malignant melanoma has significantly increased in most of the countries.(1,2) Cutaneous melanoma is the most frequent cause of mortality from skin cancer.”
BackgroundSelf-citationHsu, S.-H., Wen, C.-J., Al‐Suwayeh, S. A., Huang, Y., & Fang, J. (2013) · Nanomedicine · doi:10.2217/nnm.12.170 · Cited by 35
Aspirin for the primary prevention of skin cancer: A meta-analysis
Zhu, Y., Cheng, Y., Luo, R., & Li, A. (2015) · Oncology Letters · doi:10.3892/ol.2015.2853 · Cited by 34
“The incidence of skin cancer, particularly MM, is increasing, with an annual growth rate of 3-5% in the USA, and appropriate preventive approaches are urgently required (3,4).”
Botanicals for the prevention and treatment of cutaneous melanoma
Syed, D. N., & Mukhtar, H. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00851.x · Cited by 35
“Surgery remains the cornerstone of curative treatment in earlier stages (Mackie et al., 2009).”
BackgroundInfluentialSoares, A., Costa, V. M., Diniz, C., & Fresco, P. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12280 · Cited by 35
Sentinel Lymph Node Biopsy Use Among Melanoma Patients 75 Years of Age and Older
Sabel, M. S., Kozminski, D. J., Griffith, K. A., Chang, A. E., Johnson, T. M., & Wong, S. L. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4539-7 · Cited by 33
Melanoma risk after ovarian stimulation for in vitro fertilization
Spaan, M., van den Belt‐Dusebout, A. W., Schaapveld, M., Mooij, T. M., Burger, C. W., van Leeuwen, F. E., on behalf of the OMEGA-project group, Schats, R., Lambalk, C. B., Kortman, M., et al. (2015) · Human Reproduction · doi:10.1093/humrep/dev023 · Cited by 35
“During the last 50 years the incidenceofmelanomahas increased steadily in mostWestern countries (Karim-Kos et al., 2008; MacKie et al., 2009; Tucker, 2009; Hollestein et al., 2012).”
Background
Metadata
- Authors
- MacKie, R. M., Hauschild, A., & Eggermont, A. M. M.
- Affiliations
- University of Glasgow (GB)
- Christian-Albrechts-Universität zu Kiel (DE)
- Erasmus MC (NL)
- Corresponding author
- MacKie, R.M.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 20
- Pages
- vi1-vi7
- ISSN
- 0923-7534 (ISSN-L)
- PMC
- PMC2712590
- OpenAlex
- W2138414111
- Cited by
- 405
- References
- 55
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 14 · 2023: 11 · 2022: 15 · 2021: 37 · 2020: 19 · 2019: 22 · 2018: 17 · 2017: 18 · 2016: 23 · 2015: 37 · 2014: 32 · 2013: 34 · 2012: 38
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc/4.0/ (vor, 3800 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Keywords
- cutaneous melanoma, melanoma incidence, incidence trends, risk factors, melanoma susceptibility genes, UV exposure, sex hormones, socioeconomic status, occupational exposure, pesticide exposure, immunosuppressants, nonsteroidal anti-inflammatory drugs, melanoma screening, dermoscopy, melanoma survival, melanoma mortality
- MeSH terms
- Humans, Melanoma, Neoplasm Invasiveness, Risk Factors, Skin Neoplasms, Global Health, Survival Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.